OCD drug spotlighted as potential COVID-19 treatment
Despite a highlight story on 60 Minutes last month, fluvoxamine, a drug typically used to treat obsessive-compulsive disorder (OCD), is still just a brief mention in the "cytokine inhibitors" section in the For now, it makes sense. Fluvoxamine, a serotonin reuptake inhibitor (SSRI), has shown promise in two smaller studies, but larger trials have not been published yet. Even if the drug becomes a more mainstream treatment for COVID-19, one expert says any demand surge is not expected to result in shortages. COVID-19 treatment potential As 60 Minutes tells it, the first COVID-19–related f...
Source: umn.edu